Navigation Links
Patent and Trademark Assets Related to Absorbable Surgical Adhesives and Sealants Owned by Cohera Medical Inc® to Sell on February 25, 2019 in Private Auction
Date:2/6/2019

Ocean Tomo Transactions has been retained by DCI Assignments, LLC, the Assignee of Cohera pursuant to an Assignment for the Benefit of Creditors, to conduct a private auction of the Cohera Medical Inc® absorbable surgical adhesives and sealants global patents, open applications and trademarks. The sale is by order the Chancery Court for the State of Delaware.

Subject to any approval that may be required by the Chancery Court for the State of Delaware in connection with the Assignment for the Benefit of Creditors of Cohera®, the highest bid as of February 25, 2019 (Midnight, PST) in the private auction, will acquire the intellectual property assets for the formulation, delivery device and methods covered by the Cohera surgical adhesive and sealants intellectual property.

Marketed by Cohera under the trade name TissuGlu®, the practice of the art disclosed in the patents resulted in the first 100% synthetic internal surgical adhesive approved for sale in the United States. TissuGlu, designed to meet a surgeon’s need for a strong, biocompatible and easy-to-use surgical adhesive, is an alternative to the use of postoperative fluid collection drains in mastectomy surgeries. It was also approved in the US for the approximation of tissue layers where subcutaneous dead space exists between tissue planes in abdominoplasty; TissuGlu passed all bio-compatibility testing as a Class III permanent implant.

With the market for surgical drains projected to rise from it’s estimated 2018 value of $1.90 billion USD to an estimated value of $2.64 billion USD by 2026, the acquirer of this portfolio of issued patents, pending applications and trademarks will have intellectual property assets with both early priority dates and important open applications in the areas of hydrophilic adhesives, pressure sensitive adhesives, spray and drop dispenser technologies.

In March of 2018, Cohera submitted a Premarket Approval Application (PMA) supplement to the U.S. Food and Drug Administration (FDA) for TissuGlu Surgical Adhesive providing new clinical evidence supporting a review by the FDA to expand the indication for TissuGlu in the US for mastectomy, pressure ulcer and other breast procedures with a combined addressable market exceeding $1 billion USD.

For further details on the portfolio, the private auction or to request an NDA for further access to a confidential presentation on this portfolio, contact Dean Becker, DeanBecker@OTI.com or +1-251-262-0000 (PST).

About Ocean Tomo

Ocean Tomo, the Intellectual Capital Merchant Banc™ firm provides companies with financial services related to intellectual property and intangible assets.
Collectively, Ocean Tomo professionals have:

  • Executed over 1000 engagements involving IP worth in excess of $10 billion;
  • Successfully closed transactions where disruptive technology played a key role, with cumulative value in excess of $750 million;
  • Conducted over 300 valuation engagements and 500 financial damages expert testimony engagements.

Ocean Tomo assists clients – corporations, law firms, governments and institutional investors – in realizing Intellectual Capital Equity®value broadly defined.

About DSI

Development Specialists, Inc. (DSI) is one of the leading providers of management consulting and financial advisory services, including turnaround consulting, financial restructuring, litigation support and forensic accounting. Our clients include business owners, private-equity investors, corporate boards, financial institutions, secured lenders, bondholders and unsecured creditors. For almost 40 years, DSI has been guided by a single objective: maximizing value for all stakeholders. With our highly skilled and diverse team of professionals, offices in the U.S. and international affiliates, and an unparalleled range of experience, DSI not only achieves that objective, but has also built a solid reputation as an industry leader.

Read the full story at https://www.prweb.com/releases/patent_and_trademark_assets_related_to_absorbable_surgical_adhesives_and_sealants_owned_by_cohera_medical_inc_to_sell_on_february_25_2019_in_private_auction/prweb16084779.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine technology :

1. Compound Solutions Aggressively Pursues Patent Violators of its goBHB® ketone
2. Metrasens Acquires New Patents to Further Protect Its Innovative Technology
3. World’s First Chocolate Patent for Weight and Cholesterol Management Granted in Europe
4. Kalypso Wellness Centers Moves to Secure Patent for Ketamine Treatments
5. LifeWIRE in the top 10 health related patents recognized for innovation and global impact by ACT: THE APP ASSOCIATION
6. CellMax Life Blood Testing Platform for Early Cancer Detection Granted Six U.S. Patents
7. Lilly Reaches Settlement Agreement in U.S. Cialis Patent Litigation
8. Oramed Granted Canadian Patent for GLP-1 Analog Capsule
9. Vivify Health Awarded Patent for Extending EMRs with Digital Health
10. Jazz Pharmaceuticals Reaches Settlement with Hikma Pharmaceuticals Related to Xyrem Patent Litigation
11. Patent Case of Carl Zeiss Meditec AG and VSY Biotechnology B.V.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2019)... ... April 17, 2019 , ... Lillibridge Healthcare Services Inc., a ... owners and operators of medical office buildings (MOBs), will sponsor and host three ... Owners and Managers Association (BOMA) International Medical Office Buildings + Healthcare Facilities Conference ...
(Date:4/17/2019)... ... April 17, 2019 , ... With the US Food ... to Expedite Development of Oncology Drugs and Biologics’ – it opens ... years of experience helping sponsors manage complex oncology trials, endpoint has ...
(Date:4/17/2019)... and BRAINTREE, Mass. (PRWEB) , ... ... ... Analytics, Inc. dba MyMedicalShopper , a leading provider of healthcare price ... third-party administrator based in Massachusetts, are partnering to give consumers more choice ...
Breaking Medicine Technology:
(Date:4/19/2019)... ... ... It's time to try a better alternative. Why use a topical dandruff ... those pesky dandruff flakes reach your scalp’s surface, making your life miserable. Tell dandruff ... you. New Don’t Flake Me Out Dandruff & Itchy Scalp Rescue is ...
(Date:4/19/2019)... Calif. (PRWEB) , ... April 18, 2019 , ... Edens ... continues to expand. The deodorants combine the power of 100% pure essential oils and ... works. , Not only is Edens Garden’s latest product release all-natural but baking ...
(Date:4/19/2019)... DALLAS (PRWEB) , ... April 19, 2019 , ... ... Ashley Doyle, RN/Patient Advocate Manager, The University of Vermont Health Network-CVPH, Plattsburgh, NY ... contributions to the field of patient advocacy and to fellow patient advocates. Doyle ...
(Date:4/18/2019)... HELSINKI and DANVERS, Mass. (PRWEB) , ... April ... ... traditional radiotherapy and proton therapy, with the ability to deliver targeted radiation to ... replaces the nuclear reactor in traditional BNCT research platforms. Engineered from the ground ...
(Date:4/18/2019)... , ... April 18, 2019 , ... ... on enhancing energy, concentration, memory, relaxation and restful sleep to support a healthy ... formulated to provide mental clarity, focus and vitality. , The portfolio includes a ...
Breaking Medicine News(10 mins):